LTR Pharma (ASX:LTP) Institutional Ownership: 0.04% (As of Jul. 06, 2026)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.58
! 1 Warning Sign
View Full Analysis

What is LTR Pharma Institutional Ownership?

LTR Pharma ASX:LTP 15 Institutional Ownership is 0.04% as of Jul. 06, 2026. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LTR Pharma's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LTR Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LTR Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

LTR Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Institutional Ownership Chart

LTR Pharma Historical Data

The historical data trend for LTR Pharma can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.07 0.07 0.07 0.04 0.04 0.04 0.04 0.04 0.04 0.04
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.04% mean?
LTR Pharma (ASX:LTP) has a Institutional Ownership of 0.04% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Institutional Ownership too high?
LTR Pharma's current Institutional Ownership is 0.04%. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Institutional Ownership compare to VRTX and REGN?
LTR Pharma's Institutional Ownership of 0.04% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on LTR Pharma and its competitors. LTR Pharma's current Institutional Ownership is 0.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Institutional Ownership of 0.04%. The current Institutional Ownership is 0.04%. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Institutional Ownership is 0.04% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.58
Price